Complex relations of genetic polymorphisms with nutritionally influenced biomarkers

American Journal of Clinical Nutrition

Volumn 95, Issue 5, 2012, Pages 1001-1002

  Glynn, Robert J ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ALPHA TOCOPHEROL; APOLIPOPROTEIN E; ASCORBIC ACID; BETA CAROTENE; CHOLESTEROL; HOMOCYSTEINE;

AGE; ALLELE; AMINO ACID BLOOD LEVEL; CANCER INCIDENCE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CIGARETTE SMOKING; DISEASE ASSOCIATION; EDITORIAL; GENE MUTATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; ISCHEMIC HEART DISEASE; NUTRITIONAL PARAMETERS; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; STROKE; SYSTOLIC BLOOD PRESSURE;

CARDIOVASCULAR DISEASES; FEMALE; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2);

EID: 84860267096     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.112.037655     Document Type: Editorial

References (10)

1. Yang Q, Bailey L, Clarke R, Flanders WD, Liu T, Yesupriya A, Khoury MJ, Friedman JM. Prospective study of methylenetetrahydroflate reductase (MTHFR) variant C677T and risk of all-cause and cardiovascular disease mortality among 6000 US adults. Am J Clin Nutr 2012;95:1245-53.
2. Christen WG, Ajani UA, Glynn RJ, Hennekens CH. Blood levels of homocysteine and increased risks of cardiovascular disease: causal or casual? Arch Intern Med 2000;160:422-34. (Pubitemid 30112266)
3. The Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA 2002;288: 2015-22.
4. Jacques PF, Bostom AG, Wilson PWF, Rick S, Rosenberg IH, Selhub J. Determinants of plasma total homocysteine concentration in the Framingham Offspring cohort. Am J Clin Nutr 2001;73:613-21. (Pubitemid 32176514)
5. Angrist JD, Imbens GW, Rubin DB. Identification of causal effects using instrumental variables. J Am Stat Assoc 1996;91:444-55. (Pubitemid 126412813)
6. Katan MB. Commentary: Mendelian randomization, 18 years on. Int J Epidemiol 2004;33:10-1. (Pubitemid 38500146)
7. Clarke R, Bennett DA, Parish S, Verhoef P, Dötsch-Klerk M, Lathrop M, Xu P, Nordestgaard BG, Holm H, Hopewell JC, et al MTHFR Studies Collaborative Group. Homocysteine and coronary heart disease: meta-analysis of MTHFR case-control studies, avoiding publication bias. PLoS Med 2012;9:e1001177.
8. Holmes MV, Newcombe P, Hubacek JA, Sofat R, Ricketts SL, Cooper J, Breteler MM, Bautista LE, Sharma P, Whittaker JC, et al. Effect modification by population dietary folate on the association between MTHFR genotype, homocysteine, and stroke risk: a meta-analysis of genetic studies and randomised trials. Lancet 2011;378:584-94.
9. Nitsch D, Molokhia M, Smeeth L, DeStavola BL, Whittaker JC, Leon DA. Limits to causal inference based on Mendelian randomization: a comparison with randomized controlled trials. Am J Epidemiol 2006; 163:397-403.
10. Rothman KJ, Greenland S. Causation and causal inference in epidemiology. Am J Public Health 2005;95(suppl 1):S144-50. (Pubitemid 41033428)